Xiang, S. et al. [83] have described how the use of melatonin in MCF7 breast cancer cells (1 nM) in vitro represses RORα transactivation through the MT1 receptor activation pathway, leading to the suppression of Bmal1 mRNA expression. The gene discussed is BMAL1; the disease is breast carcinoma.